Roivant Sciences Ltd. Common Shares Share Price
NASDAQ: ROIVHealthcare
Live Roivant Sciences Ltd. Common Shares Share Price Chart
O H L
Roivant Sciences Ltd. Common Shares Performance Overview
Days Range
▼
$39.75Low
$40.16High
Markets Today
| Previous Close | $39.98 |
|---|---|
| Open | $40.16 |
| Volume | 988,314 |
| Day's Range | $39.75 - $40.16 |
| 52W Range | $14.50 - $42.50 |
| Market Cap | $28.58 B |
Historical Performance
| 1M Returns | +6.98 |
|---|---|
| 3M Returns | +27.20 |
| 6M Returns | +43.81 |
| 1Y Returns | +164.94 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Roivant Sciences Ltd. Common Shares Fundamentals
| Market Cap | $28.58 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $8.26 M |
| ROE TTM | -0.07 |
| EPS TTM | $-0.39 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.76 |
| EBITDA | $-1.28 B |
| Profit Margin | -3629.19 |
| Market Cap | $28.58 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $8.26 M |
| ROE TTM | -0.07 |
| EPS TTM | $-0.39 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.76 |
| EBITDA | $-1.28 B |
| Profit Margin | -3629.19 |
Roivant Sciences Ltd. Common Shares Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $7.57 M | $2.17 M | $1.57 M | $2.00 M | $2.52 M | $1.44 M |
| Gross Profit + | $7.57 M | $2.17 M | $1.57 M | $2.00 M | $2.52 M | $1.44 M |
| Operating Income | -$284.96 M | -$284.92 M | -$306.23 M | -$339.15 M | $415.24 M | -$365.99 M |
| EBITDA | -$283.54 M | -$283.82 M | -$305.31 M | -$338.46 M | -$354.36 M | -$365.79 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $1.43 M | $1.10 M | $921.00 K | $691.00 K | -$769.60 M | $208.00 K |
| Income Before Tax | -$203.05 M | -$269.26 M | -$159.04 M | -$290.37 M | $454.10 M | -$294.56 M |
| Income Tax Expense | $49.32 M | $4.65 M | $7.00 M | $23.33 M | $98.35 M | -$3.96 M |
| Net Income + | -$252.38 M | -$273.91 M | -$166.04 M | -$313.70 M | $355.74 M | -$290.61 M |
| Net Profit Margin | -3333.88% | -12622.63% | -10569% | -15692.9% | 14116.83% | -20152.98% |
Roivant Sciences Ltd. Common Shares Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $0 | $0 | $0 | $0 | $0 | $0 |
| Reserve & Surplus | $125.50 M | -$298.45 M | -$409.55 M | -$674.39 M | -$497.46 M | -$899.65 M |
| Non-Current Liabilities | $100.33 M | $102.83 M | $123.28 M | $99.18 M | $135.03 M | $101.02 M |
| Current Liabilities | $149.41 M | $113.87 M | $133.86 M | $151.96 M | $281.24 M | $283.60 M |
| Total Liabilities | $249.74 M | $216.70 M | $257.14 M | $251.14 M | $416.27 M | $384.62 M |
| Fixed Assets | $12.06 M | $14.87 M | $25.67 M | $13.45 M | $11.99 M | $11.32 M |
| Current Assets | $5.00 B | $4.62 B | $4.51 B | $4.66 B | $5.17 B | $4.74 B |
| Total Assets | $5.44 B | $5.03 B | $5.06 B | $5.23 B | $5.71 B | $5.31 B |
Roivant Sciences Ltd. Common Shares Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$252.38 M | -$273.91 M | -$166.04 M | -$313.70 M | $355.74 M | -$290.61 M |
| Operating Cash Flow | -$172.56 M | -$204.38 M | -$185.66 M | -$196.48 M | -$163.82 M | -$270.50 M |
| Investing Cash Flow | $1.07 B | -$1.09 B | $120.42 M | $109.47 M | $173.49 M | $281.26 M |
| Financing Cash Flow | -$177.15 M | -$187.77 M | $62.59 M | $328.19 M | -$68.78 M | -$181.51 M |
| Change in Cash | $723.99 M | -$1.48 B | -$1.45 M | $241.61 M | -$57.79 M | -$170.44 M |
Roivant Sciences Ltd. Common Shares Return Calculator
The Roivant Sciences Ltd. Common Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Roivant Sciences Ltd. Common Shares
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Popular Stocks
FAQs
What is the share price of Roivant Sciences Ltd. Common Shares today?
Roivant Sciences Ltd. Common Shares (ROIV) share price as of September 18, 2026 is $39.88. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Roivant Sciences Ltd. Common Shares?
Yes, Indian Investors can invest in the Roivant Sciences Ltd. Common Shares (ROIV) Share by opening an international trading account with Angel One.
How can I purchase Roivant Sciences Ltd. Common Shares shares in India?
Purchasing Roivant Sciences Ltd. Common Shares (ROIV) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Roivant Sciences Ltd. Common Shares (ROIV) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Roivant Sciences Ltd. Common Shares?
Yes, you can purchase fractional shares of Roivant Sciences Ltd. Common Shares (ROIV) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Roivant Sciences Ltd. Common Shares?
The market capitalization of Roivant Sciences Ltd. Common Shares on September 18, 2026, is $28.58 B.
In which sector Roivant Sciences Ltd. Common Shares belongs?
Roivant Sciences Ltd. Common Shares operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Roivant Sciences Ltd. Common Shares stocks?
In order to invest in Roivant Sciences Ltd. Common Shares (ROIV) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
